文献速递其他结缔组织病

OMERACT灰阶超声评分系统在疑似干燥综合征患者唾液腺中的应用

Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren's syndrome.
PubMed 文献 · RMD Open · 2021-01-01

单中心12个月纳入134例疑似干燥综合征患者,采用OMERACT超声评分系统评估唾液腺。43例诊断为原发性干燥综合征(pSS)且均满足2016 ACR/EULAR分类标准。以至少一个腺体评分≥2为最佳诊断切点,敏感度0.72、特异度0.91。

要点

  • pSS患者中72%至少一个腺体评分≥2,非pSS仅13%(p<0.001)。
  • 最佳诊断切点为至少一个腺体评分≥2,敏感度0.72、特异度0.91。
  • 评分≥2者自身抗体、唾液流率、Schirmer试验及唇腺活检阳性比例更高。

核心结论

  • OMERACT超声评分系统以至少一个腺体评分≥2为切点,对满足2016 ACR/EULAR分类标准具有良好敏感度(0.72)和优秀特异度(0.91)。

研究设计与样本

  • 单中心12个月纳入所有疑似干燥综合征的转诊患者,共134例进行分析。
  • 所有患者临床检查前接受腮腺及下颌下腺灰阶超声,并按OMERACT评分系统对四个腺体行0-3分评分。

主要发现

  • 134例中43例诊断为pSS,且全部满足2016 ACR/EULAR分类标准。
  • pSS患者至少一个腺体评分≥2的比例为72%,非pSS为13%(p<0.001)。
  • 评分≥2的患者中自身抗体阳性、唾液流率异常、Schirmer试验阳性及唇腺活检阳性的比例显著高于评分≤1者。

关键数值与推荐

  • 诊断pSS的最佳超声切点为至少一个腺体评分≥2,敏感度0.72、特异度0.91。
  • pSS患者至少一个腺体评分≥2的比例为72%,非pSS为13%(p<0.001)。

临床怎么用

  • 对疑似干燥综合征患者可行唾液腺灰阶超声,以至少一个腺体评分≥2作为提示pSS的切点。
  • 超声评分≥2与自身抗体、唾液流率、Schirmer试验及唇腺活检阳性相关,可辅助诊断评估。

局限性

  • 单中心研究,样本量134例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To describe salivary gland involvement in patients suspected of Sjögren's syndrome (SS) using the OMERACT Ultrasound Scoring System for SS. Next, using different ultrasound cut-offs, to assess the performance of the scoring system for diagnosis and fulfilment of 2016 ACR/EULAR SS classification criteria. METHODS: All patients referred to our department with a suspicion of SS in a 12-month period were included. All underwent grey-scale ultrasound of the parotid and submandibular glands prior to clinical examination, Schirmer's test, unstimulated salivary flow, blood samples including autoantibody analysis. Labial biopsy was performed according to clinicians' judgement. Images of the four glands were scored 0-3 according to the scoring system and a consensus score was obtained using a developed ultrasound atlas. RESULTS: Of the 134 patients included in the analysis, 43 were diagnosed with primary SS (pSS) and all fulfilled the 2016 American College of Rheumatology (ACR)/EULAR classification criteria. More patients with pSS compared with non-pSS had score ≥2 in at least one gland (72% vs 13%; p<0.001). In patients with score ≥2 in any gland, significantly more had positive autoantibodies, sialometry, Schirmer's test and positive labial biopsy compared with those with scores ≤1. The best ultrasound cut-off value for diagnosing pSS was ≥1 gland with a score ≥2 (sensitivity=0.72, specificity=0.91). CONCLUSION: The OMERACT Ultrasound Scoring System showed good sensitivity (0.72) and excellent specificity (0.91) for fulfilling 2016 ACR/EULAR criteria using cut-off score >2 in at least one gland. Our data supports the use of ultrasound for diagnosing pSS and supports incorporation of ultrasound in the classification criteria.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Fana V, Dohn UM, Krabbe S, et al. Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren's syndrome. RMD Open. 2021. PMID: 33879581. doi:10.1136/rmdopen-2020-001516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。